A REVOLUTION IN IVF TECHNOLOGY
Founded in 2018, TMRW Life Sciences, Inc. is a life sciences technology company that provides safety and transparency to modernize and transform the field of IVF. For the first time, frozen eggs and embryos can be digitally identified and tracked, safely managed with automated robotics, and remotely monitored 24/7. With proprietary RFID-enabled labware and an integrated software management solution, TMRW safeguards life's most precious cells.
TMRW, named Fast Company's #1 Most Innovative Biotech company in 2022, has been adopted by leading clinics across the US and will soon be available in the UK and Europe.
With significant continued growth in fertility services and the projected number of IVF births on the rise, TMRW provides a scalable solution for clinics bringing the care of frozen eggs and embryos into the 21st century.
TMRW, named Fast Company's #1 Most Innovative Biotech company in 2022, has been adopted by leading clinics across the US and will soon be available in the UK and Europe.
With significant continued growth in fertility services and the projected number of IVF births on the rise, TMRW provides a scalable solution for clinics bringing the care of frozen eggs and embryos into the 21st century.
OUR CORE VALUES
At TMRW, we think of our values as our human operating system. They guide us. They inspire us and provide the guardrails for the work we do and how we work together. They remind us of the incredible responsibility we share and our commitments to all we partner with. Our values represent not just who we are as individuals but our collective promise to each other. We think and act in accordance with our values; we show up with them in mind and hold each other accountable.
We developed the statement of our values with broad input from across every department and every level of our company. Each of us represents our values.
They are our teamtmrwOS.
For the first time, TMRW's advanced Digital Specimen Management platform is combined with the convenience of a manual liquid storage tank.
Partnership of ISO-Certified leaders to deliver trusted IVF specimen management and transport solutions.
Our Series D was led by 5AM Ventures with participation from FIOS Venture Holdings, DF Investment Partners, Transformation Capital, Life Sciences Innovation Fund, and Casdin Capital.
TMRW expands growing network of offsite cryostorage facilities
TMRW's Digital Specimen Management Now Available With or Without Automated Storage
Following uncertainty over reproductive healthcare as a result of the Alabama Supreme Court decision, TMRW offers patients one year free storage at their biorepository.
The Hewitt Fertility Centre is the First UK Clinic to Adopt TMRW
The CE Mark confirms TMRW's CRS platform meets applicable European Medical Device Regulation requirements.
Lou Villalba transitions from Chief Business Officer to CEO.
Pinnacle Fertility Adopts TMRW's State-of-the-Art Technology for the Safe Management & Storage of Frozen Eggs & Embryos
The only FDA-cleared automated solution that digitally tracks, monitors, and stores frozen eggs and embryos in IVF.
The most modern and safest repository in the world is devoted exclusively to Fertility tissue.
CCRM Fertility announces they will expand the adoption of TMRW into all their IVF clinics in North America.
TMRW was ranked first on Fast Company’s 2022 List of Most Innovative Biotech Companies.
TMRW's core technology was validated in a study undertaken with CCRM, one of the world's most celebrated IVF centers.
Transformation Capital led our Series C.
Our CryoRobot met the requirements of Directive 93/42/EEC for medical devices in the UK and EU.
ISO 13485 is the industry standard for regulating medical devices and related services.
5AM Ventures led our Series B.
Four IVF clinics in the United States partnered with TMRW by signing study agreements.
Our Series A was led by Special Situations’ Life Sciences Innovation Fund.
TMRW became the first automated specimen management solution for IVF processes.
